LATEST NEWS

EXACT Therapeutics restarts Phase I ACTIVATE study

Norwegian Exact Therapeutics Raises NOK 155 Million and Lists On Oslo Stock Exchange’s Merkur Market

Norwegian EXACT Therapeutics Appoints Dr. Rafiq Hasan as CEO

Phoenix Solutions and their ongoing ACTivate Trial featured on the NRK
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer